Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01403688 · ClinicalTrials.gov registry record
Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and Gonadotropin
A clinical trial, sponsored by University of Kansas.
- Completed
- Registry status
- 9
- Enrollment target
NCT01403688: Completed study, sponsored by University of Kansas.
NCT01403688 is a clinical trial that has completed, run by University of Kansas. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01403688 has completed, sponsored by University of Kansas.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
Fertility drugs have the effect of increasing hormone levels. Higher hormone levels from infertility treatments may increase breast cancer risk, but there has not been enough research to know for sure. Researchers want to use a method of taking breast tissue cells from women who are having infertility treatment. The breast tissue cells might show changes that would indicate an increased risk of cancer. The method of taking the breast tissue cells is called Fine Needle Aspiration (FNA). The purpose of this study is to examine the changes in breast tissue, in women at high risk of breast cancer who are being treated with controlled ovarian hyperstimulation.
Interventions
- PROCEDURE RPFNA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2011-06 |
| Est. Completion | 2014-08 |
What the finished NCT01403688 record still lists
NCT01403688 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which RPFNA is the first listed.
NCT01403688 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01403688 about?
NCT01403688 is a clinical study titled "Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and Gonadotropin". Fertility drugs have the effect of increasing hormone levels. Higher hormone levels from infertility treatments may increase breast cancer risk, but there has not been enough research to know for sure. Researchers want to use a method of taking breast tissue cells from women who are having infertili...
What is the current status of trial NCT01403688?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2011-06. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01403688?
The interventions under investigation include: RPFNA (PROCEDURE).
Who is sponsoring clinical trial NCT01403688?
This trial is sponsored by University of Kansas, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia